| pubmed-article:8752234 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C0022876 | lld:lifeskim |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C0030095 | lld:lifeskim |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:8752234 | lifeskim:mentions | umls-concept:C0164398 | lld:lifeskim |
| pubmed-article:8752234 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8752234 | pubmed:dateCreated | 1996-10-17 | lld:pubmed |
| pubmed-article:8752234 | pubmed:abstractText | To evaluate the minimal effective dose regimen of the oxytocin antagonist atosiban in the treatment of acute preterm labor and the effect of a bolus on uterine activity within the first 2 hours compared with no bolus and the same infusion rate. | lld:pubmed |
| pubmed-article:8752234 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8752234 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8752234 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8752234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8752234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8752234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8752234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8752234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8752234 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8752234 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:8752234 | pubmed:issn | 0029-7844 | lld:pubmed |
| pubmed-article:8752234 | pubmed:author | pubmed-author:SilverHH | lld:pubmed |
| pubmed-article:8752234 | pubmed:author | pubmed-author:ValenzuelaG... | lld:pubmed |
| pubmed-article:8752234 | pubmed:author | pubmed-author:GoodwinT MTM | lld:pubmed |
| pubmed-article:8752234 | pubmed:author | pubmed-author:CreasyGG | lld:pubmed |
| pubmed-article:8752234 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8752234 | pubmed:volume | 88 | lld:pubmed |
| pubmed-article:8752234 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8752234 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8752234 | pubmed:pagination | 331-6 | lld:pubmed |
| pubmed-article:8752234 | pubmed:dateRevised | 2009-10-26 | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:meshHeading | pubmed-meshheading:8752234-... | lld:pubmed |
| pubmed-article:8752234 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8752234 | pubmed:articleTitle | Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. | lld:pubmed |
| pubmed-article:8752234 | pubmed:affiliation | University of Southern California, Los Angeles, USA. | lld:pubmed |
| pubmed-article:8752234 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8752234 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8752234 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8752234 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8752234 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8752234 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8752234 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8752234 | lld:pubmed |
